CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley Adjusts PT on Zentalis Pharmaceuticals to $5 From $4, Maintains Equalweight Rating

Positive
AI Analysis

Summary

Morgan Stanley raised its price target on Zentalis Pharmaceuticals to $5 from $4 while maintaining an Equalweight rating.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 7, 2026 9:31 AM

Read Original